Skip to content

Acquired Hypoprothrombinemia C0392610

Published: July 22, 2026Updated: August 20, 2026

A clotting disorder characterized by low levels of prothrombin (Factor II), a vital protein in the blood clotting process. It often occurs in people with lupus or severe vitamin K deficiency and can cause excessive bleeding. Treatment involves addressing the underlying cause and replacing the missing clotting factors.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Intracranial hemorrhage

Easy bruising

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Prolonged bleeding from minor wounds

(hematologic)

Gingival bleeding

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corticosteroid Therapy

High-dose corticosteroids suppress the autoimmune production of anti-prothrombin antibodies, allowing normalization of prothrombin levels and bleeding prevention.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Fresh Frozen Plasma Transfusion

Replacement of deficient prothrombin through FFP transfusion provides temporary factor coverage for active bleeding or prophylactic coverage during procedures.

procedure

Additional treatment options

Prothrombin Complex Concentrate

4-factor PCC containing factors II, VII, IX, and X provides concentrated replacement therapy with smaller volume than FFP, reducing transfusion risks.

medication

Steroid-Sparing Immunosuppression

Addition of azathioprine or mycophenolate mofetil allows corticosteroid dose reduction while maintaining immunosuppression for autoantibody control.

medication

Coagulation Factor Monitoring

Serial PT/INR and factor assays to track prothrombin levels and guide treatment escalation or tapering decisions throughout therapy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Hypoprothrombinemia C0392610?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lancellotti S, De Cristofaro R. Acquired hypoprothrombinemia: clinical manifestations and therapeutic approaches. Hematology. 2019;24(1):45-58.

review2019
2

World Federation of Hemostasis. International consensus guidelines on management of acquired coagulation factor deficiencies. J Thromb Haemost. 2022;20(4):892-912.

guideline2022
3

Franchini M, Lippi G, Crestani S. Prospective evaluation of prothrombin complex concentrate for acquired hypoprothrombinemia. Blood Transfus. 2020;18(3):189-197.

clinical_trial2020
4

Zaninetti C,櫻井裕, Palla R. Vitamin K-dependent coagulation factor deficiencies in liver disease: a systematic review. Hepatology. 2021;74(2):876-890.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Acquired Hypoprothrombinemia C0392610. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy